Rupan Trikha
Ophthalmology · Little Silver, NJNPI 1003033689
Payments from drug & device makers
Across 15 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alimera Sciences, Inc.$74
- Genentech USA, Inc.$65
- Regeneron Healthcare Solutions, Inc.$43
- Apellis Pharmaceuticals, Inc.$31
- Eyepoint US, Inc.$22
- Neurotech Pharmaceuticals, Inc.$18
- plus $16 from 1 others
What the payments were for
- Food & beverage$270100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alimera Sciences, Inc. | 4 | $74 |
| Genentech USA, Inc. | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $43 |
| Apellis Pharmaceuticals, Inc. | 2 | $31 |
| Eyepoint US, Inc. | 1 | $22 |
| Neurotech Pharmaceuticals, Inc. | 1 | $18 |
| Spark Therapeutics, Inc. | 1 | $16 |
How this compares
$270 in reported general payments places this provider in the 20th percentile of 583 ophthalmology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 17 | $3,841 |
| Ketorolac Tromethamine | 72 | $2,352 |
| Difluprednate | 22 | $1,705 |
| Brimonidine Tartrate | 27 | $1,061 |
| Prednisolone Acetate | 24 | $959 |
| Latanoprost | 47 | $796 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 47 | $561 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 41 | $418 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Little Silver
- Martin UramLittle Silver$53K
- Patrick HigginsBloomfield$16.7M
- Jai ParekhWoodland Park$2.1M
- Eric MannDover$860K
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Luis Gonzalez GonzalezTeaneck$727K
- Cynthia MatossianPennington$726K
- Charles CraneSouth Orange$582K
- Albert KhouriNewark$542K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.